This suggests that high SRGN expression may drive a dysregulated hyperinflammatory state, potentially leading to immune exhaustion or functional impairment of M1 macrophages—shifting their role from antitumor to pro-tumor effect. This evidence concerns the gene SRGN and neoplasm.